Acute erythematous oral candidosis (Q92198): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Candidíase oral caracterizada por desconforto acentuado e mucosas eritematosas atróficas despapiladas (“carecas”), particularmente no dorso da língua. Pode ocorrer após a candidíase pseudomembranosa, quando frequentemente são encontrados traços da membrana residual. Está especialmente associada à terapia antibiótica antibacteriana, mas pode se desenvolver também em indivíduos HIV-positivos e em pacientes em uso de esteróides inalatórios.
description / endescription / en
 
Oral candidosis characterised by marked soreness and denuded atrophic erythematous mucous membranes, particularly on the dorsum of the tongue. It may follow pseudomembranous candidosis, when traces of the residual membrane will often be found. It is especially associated with antibacterial antibiotic therapy, but may also develop in HIV-positive subjects and patients taking inhaled steroids.

Revision as of 07:21, 16 August 2026

Oral candidosis characterised by marked soreness and denuded atrophic erythematous mucous membranes, particularly on the dorsum of the tongue. It may follow pseudomembranous candidosis, when traces of the residual membrane will often be found. It is especially associated with antibacterial antibiotic therapy, but may also develop in HIV-positive subjects and patients taking inhaled steroids.
Language Label Description Also known as
default for all languages
ID_400350311
    English
    Acute erythematous oral candidosis
    Oral candidosis characterised by marked soreness and denuded atrophic erythematous mucous membranes, particularly on the dorsum of the tongue. It may follow pseudomembranous candidosis, when traces of the residual membrane will often be found. It is especially associated with antibacterial antibiotic therapy, but may also develop in HIV-positive subjects and patients taking inhaled steroids.

      Statements